8i Acquisition 2 Corp.

Status: Deal Closed
U=S+W+R W=S/2@$11.50 R=S/10
IPO Proceeds, $M $86.25M
IPO Date Nov 22, 2021
CEO Meng Dong (James) Tan
Left Lead Maxim
IPO Cash in Trust 100.0%
SPAC Tenor 12 + (2*3)
IPO Sector General

Asia

IPO Geography Asia
Target Company EUDA Health
Deal Announced Apr 12, 2022
Deal Size, $M $262.00M
Deal Sector Healthcare
Deal Geography Asia
SEC Filings www.sec.gov
Approval Vote Nov 10, 2022
Amendment Vote TBD
Closing Date Nov 17, 2022
Formerly LAX EUDA EUDAW

Sign up for Free Trial

No credit card required

Sign in for more on 8i Acquisition 2 Corp.:

  • Structure and cap table
  • 5 directors & officers
  • 28 filings and events
  • 1 underwriters
  • 1 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Meng Dong (James) Tan 60 CEO & Chairman
Guan Hong (William) Yap 57 CFO & Director
Kwong Yeow Liew 67 Director
Ajay Rajpal 52 Director
Alexander Arrow 50 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Maxim BR 7,500,000 units
7,500,000 units
Up-Front UW fee 4.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 28 filings.

Shareholders

Sign in to view shareholders 13F filing data.